Patients have S. suis infection with culture-confirmed S. suis infection from sterile sites (blood, pus, or cerebrospinal fluid). Streptococcus suis infections, Streptococcus suis, zoonoses, genomic, molecular epidemiology
Conditions
Interventions
Patients have S. suis infection with culture-confirmed S. suis infection from sterile sites (blood, pus, or cerebrospinal fluid).
Treatment
S. suis infection
Sponsors
Department of medicine
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Patients aged more than 18 years 2. Culture-confirmed S. suis infection from sterile sites (blood, pus, or cerebrospinal fluid)
Exclusion criteria
Exclusion criteria: None
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To investigate the association between clinical characteristics, epidemiological factors, risk factors, and clinical outcomes with bacterial genetic lineages of S. suis. 6 months Categorical variables will be presented as frequency and percentage. Continuous variables (e.g., age) will be presented as mean (standard deviation) or median with range, depending on distribution. | — |
Secondary
| Measure | Time frame |
|---|---|
| To compare the genetic dynamics of pathogenic S. suis clonal complexes. 6 months Categorical variables will be presented as frequency and percentage. Continuous variables (e.g., age) will be presented as mean (standard deviation) or median with range, depending on distribution.,To characterize the genetic traits of patients infected with S. suis. 6 months Categorical variables will be presented as frequency and percentage. Continuous variables (e.g., age) will be presented as mean (standard deviation) or median with range, depending on distribution. | — |
Countries
Thailand
Contacts
Public ContactRattagan Kajeekul
Ministry of Health
Outcome results
None listed